These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18520156)

  • 41. Enhanced production of IgE anti-Japanese cedar pollen specific antibodies by peripheral blood B cells from patients with Japanese cedar pollinosis.
    Ohshima N; Hirohata S
    Allergol Int; 2008 Jun; 57(2):147-55. PubMed ID: 18349589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma.
    Maeda Y; Akiyama K; Shida T
    Allergol Int; 2008 Dec; 57(4):413-7. PubMed ID: 18946237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soy isoflavone intake is not associated with the development of cedar pollinosis in adults.
    Nagata C; Nakamura K; Fujii K; Kawachi T; Takatsuka N; Oba S; Shimizu H
    J Nutr; 2008 Jul; 138(7):1372-6. PubMed ID: 18567763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of natural history of Japanese cedar pollinosis.
    Okawa T; Konno A; Yamakoshi T; Numata T; Terada N; Shima M
    Int Arch Allergy Immunol; 2003 May; 131(1):39-45. PubMed ID: 12759488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K; Otsuka H; Matsune S; Okubo K
    Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidemiologic study of Alnus sieboldiana Matsumura (alder) pollinosis in Ashiya city].
    Yoshimura S; Ogasawara H; Nakahara T; Fujitani T
    Arerugi; 1995 Jun; 44(6):602-8. PubMed ID: 7668998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
    Fujimura T; Kawamoto S
    Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of posterior nasal neurectomy combined with the inferior turbinate surgery for Japanese cedar pollinosis].
    Kamijo A; Kuroda Y; Hatsushika K; Nakajima M; Yamamoto T; Moriyama M; Okamoto A; Kase Y; Masuyama K
    Arerugi; 2013 May; 62(5):560-5. PubMed ID: 23760201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Investigation into the frequency of cases with Japanese cedar pollinosis among the students and staff members in our university].
    Nakamura S
    Arerugi; 1990 May; 39(5):476-82. PubMed ID: 2393353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allergen-specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season.
    Otsuka K; Otsuka H; Matsune S; Okubo K
    Immun Inflamm Dis; 2020 Sep; 8(3):258-266. PubMed ID: 32239697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [EFFECT OF PROPHYLACTIC TREATMENT BY LEUKOTORIENE RECEPTOR ANTAGONIST ON JAPANESE CEDAR POLLINOSIS OF PRE- AND POST-SCHOOL CHILDREN JAPANESE CEDAR POLLINOSIS].
    Matsune S; Saruya S; Sawaki S; Otsuka H; Oyama Y; Minowa H; Koyama M; Ikui A; Yoshioka Y; Wakayama N; Ishida M; Sekine K; Yamaguchi S; Okubo K
    Arerugi; 2016 Feb; 65(1):57-65. PubMed ID: 26923655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study.
    Uekusa Y; Inamine A; Yonekura S; Horiguchi S; Fujimura T; Sakurai D; Yamamoto H; Suzuki H; Hanazawa T; Okamoto Y
    Am J Rhinol Allergy; 2012; 26(2):92-6. PubMed ID: 22487284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sensitization and onset of Japanese cedar pollinosis in children].
    Mori A
    Arerugi; 1995 Jan; 44(1):7-15. PubMed ID: 7702455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S; Ishida S; Katayama K
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract]   [Full Text] [Related]  

  • 56. [Practical guideline for allergic rhinitis 2014 (7th edition): points of revision -prophylactic treatment for cedar pollinosis-].
    Okamoto Y
    Arerugi; 2014 Nov; 63(9):1216-22. PubMed ID: 25492876
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Takeda N
    J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
    Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M
    Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma].
    Staikūniene J; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):244-53. PubMed ID: 12695637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.